EphB1 and Ephrin-B, New Potential Biomarkers for Squamous Cell/adenosquamous Carcinomas and Adenocarcinomas of the Gallbladder |
Yuan, Yuan
(Department of Pathology, Third Xiangya Hospital, Central South University)
Yang, Zhu-Lin (Research Laboratory of Hepatobiliary Diseases, Second Xiangya Hospital, Central South University) Miao, Xiong-Ying (Research Laboratory of Hepatobiliary Diseases, Second Xiangya Hospital, Central South University) Liu, Zi-Ru (Research Laboratory of Hepatobiliary Diseases, Second Xiangya Hospital, Central South University) Li, Dai-Qiang (Department of Pathology, Second Xiangya Hospital, Central South University) Zou, Qiong (Department of Pathology, Third Xiangya Hospital, Central South University) Li, Jing-He (Department of Pathology, Basic School of Medicine, Central South University) Liang, Lu-Feng (Department of Hepatobiliary and Pancreatic Surgery, Hunan Provincial People's Hospital) Zeng, Gui-Xiang (Department of Pathology, Loudi Central Hospital) Chen, Sen-Lin (Department of Pathology, Hunan Provincial Tumor Hospital) |
1 | Miao H, Li DQ, Mukherjee A, et al (2009). EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell, 16, 9-20. DOI |
2 | Murai KK, Pasquale EB (2003). 'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci, 116, 2823-32. DOI ScienceOn |
3 | Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME (2005). EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. Am J Pathol, 167, 565-76. DOI |
4 | Nakada M, Niska JA, Miyamori H, et al (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res, 64, 3179-85. DOI |
5 | Palmer A, Klein R (2003). Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. Genes Dev, 17, 1429-50. DOI ScienceOn |
6 | Senior PV, Zhang BX, Chan ST (2010). Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line. Int J Colorectal Dis, 25, 687-94. DOI |
7 | Wu Q, Suo Z, Risberg B, et al (2004). Expression of Ephb2 and Ephb4 in breast carcinoma. Pathol Oncol Res, 10, 26-33. DOI |
8 | Kim WS, Jang KT, Choi DW, et al (2011). Clinicopathologic analysis of adenosquamous /squamous cell carcinoma of the gallbladder. J Surg Oncol, 103, 239-42. DOI ScienceOn |
9 | Kalita D, Pant L, Singh S, et al (2013). Impact of routine histopathological examination of gall bladder specimens on early detection of malignancy - a study of 4,115 cholecystectomy specimens. Asian Pac J Cancer Prev, 14, 3315-8. 과학기술학회마을 DOI ScienceOn |
10 | Kapoor VK (2006). Gallbladder cancer: a global perspective. J Surg Oncol, 93, 607-9. DOI ScienceOn |
11 | Kayaharan M, Nagakawa T (2007). Recent trends of gallbladder cancer in Japan: an analysis of 4, 770 patients. Cancer, 110, 572-80. DOI ScienceOn |
12 | Hamdani NH, Qadri SK, Aggarwalla R, et al (2012). Clinicopathological study of gallbladder carcinoma with special reference to gallstones:our 8-year experience from eastern India. Asian Pac J Cancer Prev, 13, 5613-7. DOI ScienceOn |
13 | Jubb AM, Zhong F, Bheddah S, et al (2005). EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res, 11, 5181-7. DOI ScienceOn |
14 | Lugli A, Spichtin H, Maurer R, et al (2005). EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers. Clin Cancer Res, 11, 6450-8. DOI ScienceOn |
15 | Mao YY, Jing FY, Jin MJ, et al (2013). rs12904 polymorphism in the 3'UTR of EFNA1 is associated with colorectal cancer susceptibility in a Chinese population. Asian Pac J Cancer Prev, 14, 5037-41. 과학기술학회마을 DOI ScienceOn |
16 | Batlle E , Bacant J, Begthel H, et al (2005). EphB receptor activity suppresses colorectal cancer progression. Nature, 435, 1126-30. DOI ScienceOn |
17 | Chan KM, Yu MC, Lee WC, Jan YY, Chen MF (2007). Adenosquamous/squamous cell carcinoma of gallbladder. J Surg Oncol, 95, 129-34. DOI ScienceOn |
18 | Chen J, Zhuang G, Frieden L, Debinski W (2008). Eph receptors and Ephrins in cancer: common themes and controversies. Cancer Res, 68, 10031-3. DOI ScienceOn |
19 | Davalos V, Dopeso H, Castano J, et al (2006). EphB4 and survival of colorectal cancer patients. Cancer Res, 66, 8943-8. DOI ScienceOn |
20 | Eph Nomenclature Committee (1997). Unified nomenclature for Eph family receptors and their ligands, the ephrins. Cell, 90, 403. DOI ScienceOn |
21 | Fu T, Li P, Wang H, et al (2009). c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer. J Pathol, 219, 103-13. DOI ScienceOn |
22 | Genander M, Halford MM, Xu NJ, et al (2009). Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell, 139, 679-92. DOI ScienceOn |
23 | Guo DL, Zhang J, Yuen ST, et al (2006). Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis, 27, 454-64. DOI ScienceOn |
24 | Huang J, Xiao D, Li G, et al (2013). EphA2 promotes epithelialmesenchymal transition through the Wnt/-catenin pathway in gastric cancer cells. Oncogene, 10, 238. |
25 | Kumar JR, Tewari M, Rai A, el al (2006). An objective assessment of demography of gallbladder cancer. Surg Oncol, 93, 610-4. DOI ScienceOn |